Stock data
ENDRA Life Sciences Inc. (NDRA)
ENDRA Life Sciences Inc. (NDRA) reported net income of -US$7.03M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$5.76M | -US$7.03M | — |
| 2024 | — | — | -US$10.82M | -US$11.51M | — |
| 2023 | — | — | -US$10.52M | -US$10.06M | — |
| 2022 | — | — | -US$13.16M | -US$13.18M | — |
| 2021 | — | — | -US$11.50M | -US$11.23M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | US$0.16M | — |
| 2026-03-31 | — | -US$1.31M | — |
| 2025-12-31 | — | -US$3.17M | — |
| 2025-09-30 | — | -US$1.60M | — |
| 2025-06-30 | — | -US$1.23M | — |
| 2025-03-31 | — | -US$1.04M | — |
| 2024-12-31 | — | -US$4.15M | — |
| 2024-09-30 | — | -US$2.35M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.